Wacker Biotech is “THE MICROBIAL CDMO” – your partner of choice for process development and commercial manufacturing of biopharmaceuticals (proteins, vaccines, live microbial products, and plasmid DNA (pDNA)) using microbial hosts. Developed over decades, our plug-and-play platform for pDNA is suitable for manufacturing R&D supplies (non-GMP) up to scale-up to full GMP-compliant production.

Our integrated service portfolio covers molecular biology, process- and analytical development as well as GMP manufacturing of biologics for clinical and commercial supply. Wacker Biotech maintains four GMP-compliant production plants in Amsterdam (The Netherlands), San Diego (US) and in the German cities of Jena and Halle.

TTP is an independent technology company where scientists and engineers collaborate to invent, design and develop new products and technologies.

For over 20 years, we have been working with our customers to create some of the most ground-breaking advances in cell and gene therapy tools and equipment.

Our team brings together expertise in biology, physics and engineering to enable bespoke solutions.

We support companies to reduce cost of goods and address variability and safety challenges, while scaling up new innovations. We combine our extensive experience of bioprocessing and cell handling, with our understanding of developing highly reliable medical devices – an approach we call Cell Therapy as a Medical Device (CTMD).

By using disruptive technologies and automation, TTP is advancing research, development, and manufacturing processes to make living medicines a reality for patients everywhere.

For more information, please contact cellandgene@ttp.com

Heidrick & Struggles is the premier provider of senior-level executive search, culture shaping, and leadership consulting services. We serve more than 70% of the Fortune 1000, with clients in virtually every industry and sector around the globe.

Across all our offerings, we employ data-driven methodologies honed over decades of engagements with the world’s leading organizations. Our insights enable clients to find the world’s best leaders, build diverse, inclusive cultures, and transform their teams to achieve new levels of performance.

CRB is a leading provider of sustainable engineering, architecture, construction and consulting solutions to the global life sciences and advanced technology industries. Our more than 1,000 employees provide best-in-class solutions that drive success and positive change for our clients, our people and our communities. CRB is a privately held company with a rich 35-year history of serving clients throughout the world, consistently striving for the highest standard of technical knowledge, creativity and execution.

Charter Medical, Ltd. is a recognized provider of specialty single-use products for blood management, bioprocessing, cell therapy, and regenerative medicine applications.’ Our focus is on designing and supplying single-use solutions for cell growth, frozen storage, and biological fluid handling.’ In addition to a wide variety of standard products, we specialize in developing custom closed-system designs for both small- and large-scale processing. For over 30 years, designing and manufacturing solutions and devices needed to bring new therapeutic drugs and treatments to market has been our mission.’

Charter Medical’s manufacturing plant is FD registered and our quality system is ISO-13485 certified.

CCRM, a global public-private partnership headquartered in Canada, is funded by the Government of Canada, the Province of Ontario, and leading academic and industry partners. It supports the development of regenerative medicines and associated enabling technologies, with a specific focus on cell and gene therapy. CCRM has a 40,000 square foot space dedicated to advanced cell manufacturing that includes a GMP facility for producing cells and viral vectors. CCRM accelerates the translation of scientific discovery into new companies and marketable products for patients.

ADVA Biotechnology is an innovative cell therapy solution development company. ADVA Biotechnology had developed the ADVA X3, an innovative fully controlled, end to end manufacturing solutions with a disposable kit, for immune cell therapies. ADVA X3 simplifies and enables scaled out manufacturing bringing the lifesaving therapies closer to patients. The system is powered by a wide range of controlled parameters such as pH, DO, Glucose, lactate, Glutamine and Glutamate, with a strong artificial inelegance feedback system allowing optimization and efficiency. The ADVA X3 can be remotely controlled and monitored and is self-contained allowing a real decentralized manufacturing model.

At Lonza Cell & Gene Technologies, we provide contract development and manufacturing services that enable pharma and biotech companies to realize life-changing cell & gene therapies for their patients. From the building blocks of life to the delivery of your therapy to patients, our solutions are created to simplify your outsourcing experience and provide a reliable outcome when you expect it. Our unmatched expertise in process development, paired with our standardized, systematic approach to cGMP manufacturing have already demonstrated our ability and capabilities to successfully take cell & gene therapies to commercialization time and time again. We continuously invest to solve not just the current, but also the future challenges. Together, let’s realize your life-changing therapy.